2010
DOI: 10.1038/nrc2795
|View full text |Cite
|
Sign up to set email alerts
|

Breast and prostate cancer: more similar than different

Abstract: Breast cancer and prostate cancer are the two most common invasive cancers in women and men, respectively. Although these cancers arise in organs that are different in terms of anatomy and physiological function both organs require gonadal steroids for their development, and tumours that arise from them are typically hormone-dependent and have remarkable underlying biological similarities. Many of the recent advances in understanding the pathophysiology of breast and prostate cancers have paved the way for new… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
159
0
5

Year Published

2011
2011
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 216 publications
(170 citation statements)
references
References 114 publications
6
159
0
5
Order By: Relevance
“…Strong environmental risk factors linking PCa with endocrine and nervous system tumors, myeloma, or melanoma are not apparent, and thus a genetic contribution is likely [2]. For the association with breast cancer, BRCA2 mutations may contribute; however, because the PCa association was stronger in families with a single breast cancer in comparison to those with multiple breast cancers, shared hormonal pathways may be the main common mechanism [6,7]. The RR of PCa in Swedish BRCA2 mutation carriers was reported to be only 2.3 [8].…”
Section: [ ( F I G _ 1 ) T D $ F I G ]mentioning
confidence: 99%
“…Strong environmental risk factors linking PCa with endocrine and nervous system tumors, myeloma, or melanoma are not apparent, and thus a genetic contribution is likely [2]. For the association with breast cancer, BRCA2 mutations may contribute; however, because the PCa association was stronger in families with a single breast cancer in comparison to those with multiple breast cancers, shared hormonal pathways may be the main common mechanism [6,7]. The RR of PCa in Swedish BRCA2 mutation carriers was reported to be only 2.3 [8].…”
Section: [ ( F I G _ 1 ) T D $ F I G ]mentioning
confidence: 99%
“…83 This apparent switch in TGFβ function has been reflected in a model of breast cancer progression, where it is evident TGFβ can switch from a tumor suppressor to a pro-metastatic factor. 124 At present, data showing the molecular mechanisms controlling PII aromatase gene transcription in the testis are limited, although a valuable exercise is to use information from other tissues and organs to provide potential clues from well characterized aromatase regulated tissues such as the breast and prostate, 125 and indeed many factors that have been implicated in progression of disease in these tissues are known to be present in the testis. Nonetheless, majority of data suggests that is the conjoint action of SF-1/LRH-1 and phosphorylated CREB binding to their corresponding response elements on PII that contribute to constitutive active aromatase expression.…”
Section: Molecular Mechanisms Controlling Aromatase Gene Expression Imentioning
confidence: 99%
“…The identification of genetic alterations in cancer cells is crucial for the development of more effective methods for early diagnosis, as well as to provide targets for treatment and therapeutic interventions. The analysis of the similarities and differences between breast and prostate cancers provides doi: 10.18282/amor.v2.i2.70 a fascinating picture of the natural history, biological basis and clinical features of these two endocrine-related cancers and suggest that breast and prostate cancer may represent, in some aspects, homologous cancers in females and males [3,4] . Indeed, several studies have shown that a few genes which have been widely accepted to be breast cancer-specific (e.g.…”
Section: Introductionmentioning
confidence: 99%